-
1
-
-
49149124199
-
Mechanisms of angiogenesis
-
Karamysheva, A. (2008) Mechanisms of angiogenesis. Biochemistry 73, 751-762
-
(2008)
Biochemistry
, vol.73
, pp. 751-762
-
-
Karamysheva, A.1
-
2
-
-
80054012347
-
Developmental and pathological angiogenesis
-
Chung, A. S., and Ferrara, N. (2011) Developmental and pathological angiogenesis. Annu. Rev. Cell Dev. Biol. 27, 563-584
-
(2011)
Annu. Rev. Cell Dev. Biol.
, vol.27
, pp. 563-584
-
-
Chung, A.S.1
Ferrara, N.2
-
3
-
-
0028929803
-
Angiogenesis incancer, vascular, rheumatoid and other disease
-
Folkman, J. (1995) Angiogenesis incancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31
-
(1995)
Nat. Med.
, vol.1
, pp. 27-31
-
-
Folkman, J.1
-
4
-
-
33947414473
-
VEGF-A and the induction of pathological angiogenesis
-
Nagy, J. A., Dvorak, A. M., and Dvorak, H. F. (2007) VEGF-A and the induction of pathological angiogenesis. Annu. Rev. Pathol. 2, 251-275
-
(2007)
Annu. Rev. Pathol.
, vol.2
, pp. 251-275
-
-
Nagy, J.A.1
Dvorak, A.M.2
Dvorak, H.F.3
-
5
-
-
43249095919
-
Tumor angiogenesis
-
Kerbel, R. S. (2008) Tumor angiogenesis. New Engl. J. Med. 358, 2039-2049
-
(2008)
New Engl. J. Med.
, vol.358
, pp. 2039-2049
-
-
Kerbel, R.S.1
-
6
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
Carmeliet, P., and Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249-257
-
(2000)
Nature
, vol.407
, pp. 249-257
-
-
Carmeliet, P.1
Jain, R.K.2
-
7
-
-
30744479430
-
Angiogenesis in life, disease and medicine
-
Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature 438, 932-936
-
(2005)
Nature
, vol.438
, pp. 932-936
-
-
Carmeliet, P.1
-
8
-
-
33845689574
-
VEGF/VEGFR signalling as a target for inhibiting angiogenesis
-
Kiselyov, A., Balakin, K. V., and Tkachenko, S. E. (2007) VEGF/VEGFR signalling as a target for inhibiting angiogenesis. Expert Opin. Investig. Drugs 16, 83-107
-
(2007)
Expert Opin. Investig. Drugs
, vol.16
, pp. 83-107
-
-
Kiselyov, A.1
Balakin, K.V.2
Tkachenko, S.E.3
-
9
-
-
25144511910
-
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
-
Takahashi, H., and Shibuya, M. (2005) The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. 109, 227-241
-
(2005)
Clin. Sci.
, vol.109
, pp. 227-241
-
-
Takahashi, H.1
Shibuya, M.2
-
10
-
-
33646569993
-
Biology of vascular endothelial growth factors
-
Roy, H., Bhardwaj, S., and Ylä-Herttuala, S. (2006) Biology of vascular endothelial growth factors. FEBS Lett. 580, 2879-2887
-
(2006)
FEBS Lett.
, vol.580
, pp. 2879-2887
-
-
Roy, H.1
Bhardwaj, S.2
Ylä-Herttuala, S.3
-
11
-
-
0035062394
-
The splice variants of vascular endothelial growth factor (VEGF) and their receptors
-
Robinson, C. J., and Stringer, S. E. (2001) The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114, 853-865
-
(2001)
J. Cell Sci.
, vol.114
, pp. 853-865
-
-
Robinson, C.J.1
Stringer, S.E.2
-
12
-
-
0035577770
-
Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites
-
Guo, P., Xu, L., Pan, S., Brekken, R. A., Yang, S. T., Whitaker, G. B., Nagane, M., Thorpe, P. E., Rosenbaum, J. S., Su Huang, H. J., Cavenee, W. K., and Cheng, S. Y. (2001) Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. Cancer Res. 61, 8569-8577
-
(2001)
Cancer Res.
, vol.61
, pp. 8569-8577
-
-
Guo, P.1
Xu, L.2
Pan, S.3
Brekken, R.A.4
Yang, S.T.5
Whitaker, G.B.6
Nagane, M.7
Thorpe, P.E.8
Rosenbaum, J.S.9
Su Huang, H.J.10
Cavenee, W.K.11
Cheng, S.Y.12
-
13
-
-
33646107369
-
VEGF receptor signalling: In control of vascular function
-
Olsson, A. K., Dimberg, A., Kreuger, J., and Claesson-Welsh, L. (2006) VEGF receptor signalling: in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371
-
(2006)
Nat. Rev. Mol. Cell Biol.
, vol.7
, pp. 359-371
-
-
Olsson, A.K.1
Dimberg, A.2
Kreuger, J.3
Claesson-Welsh, L.4
-
14
-
-
0026723142
-
The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules
-
Gitay-Goren, H., Soker, S., Vlodavsky, I., and Neufeld, G. (1992) The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267, 6093-6098
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 6093-6098
-
-
Gitay-Goren, H.1
Soker, S.2
Vlodavsky, I.3
Neufeld, G.4
-
15
-
-
0032549799
-
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
-
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745
-
(1998)
Cell
, vol.92
, pp. 735-745
-
-
Soker, S.1
Takashima, S.2
Miao, H.Q.3
Neufeld, G.4
Klagsbrun, M.5
-
16
-
-
0034641729
-
Heparin sequencing brings structure to the function of complex oligosaccharides
-
Nugent, M. A. (2000) Heparin sequencing brings structure to the function of complex oligosaccharides. Proc. Natl. Acad. Sci. U. S. A. 97, 10301-10303
-
(2000)
Proc. Natl. Acad. Sci. U. S. A.
, vol.97
, pp. 10301-10303
-
-
Nugent, M.A.1
-
17
-
-
0035707396
-
Structure and biological interactions of heparin and heparan sulfate
-
Casu, B., and Lindahl, U. (2001) Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 57, 159-206
-
(2001)
Adv. Carbohydr. Chem. Biochem.
, vol.57
, pp. 159-206
-
-
Casu, B.1
Lindahl, U.2
-
18
-
-
84880275146
-
Heparan sulfate-protein binding specificity
-
Nugent, M. A., Zaia, J., and Spencer, J. L. (2013) Heparan sulfate-protein binding specificity. Biochemistry 78, 726-735
-
(2013)
Biochemistry
, vol.78
, pp. 726-735
-
-
Nugent, M.A.1
Zaia, J.2
Spencer, J.L.3
-
20
-
-
0034698012
-
Potential mechanisms for the regulation of growth factor binding by heparin
-
Forsten, K. E., Fannon, M., and Nugent, M. A. (2000) Potential mechanisms for the regulation of growth factor binding by heparin. J. Theor. Biol. 205, 215-230
-
(2000)
J. Theor. Biol.
, vol.205
, pp. 215-230
-
-
Forsten, K.E.1
Fannon, M.2
Nugent, M.A.3
-
21
-
-
1942470528
-
Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly
-
Ibrahimi, O. A., Zhang, F., Hrstka, S. C., Mohammadi, M., and Linhardt, R. J. (2004) Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry 43, 4724-4730
-
(2004)
Biochemistry
, vol.43
, pp. 4724-4730
-
-
Ibrahimi, O.A.1
Zhang, F.2
Hrstka, S.C.3
Mohammadi, M.4
Linhardt, R.J.5
-
22
-
-
14644399153
-
The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling
-
Forsten-Williams, K., Chua, C. C., and Nugent, M. A. (2005) The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling. J. Theor. Biol. 233, 483-499
-
(2005)
J. Theor. Biol.
, vol.233
, pp. 483-499
-
-
Forsten-Williams, K.1
Chua, C.C.2
Nugent, M.A.3
-
23
-
-
0030847193
-
Neuropilin is a receptor for the axonal chemorepellent semaphorin III
-
He, Z., and Tessier-Lavigne, M. (1997) Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell 90, 739-751
-
(1997)
Cell
, vol.90
, pp. 739-751
-
-
He, Z.1
Tessier-Lavigne, M.2
-
24
-
-
0030829388
-
Neuropilin is a semaphorin III receptor
-
Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y.-T., Giger, R. J., and Ginty, D. D. (1997) Neuropilin is a semaphorin III receptor. Cell 90, 753-762
-
(1997)
Cell
, vol.90
, pp. 753-762
-
-
Kolodkin, A.L.1
Levengood, D.V.2
Rowe, E.G.3
Tai, Y.-T.4
Giger, R.J.5
Ginty, D.D.6
-
25
-
-
0035816698
-
Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121
-
Whitaker, G. B., Limberg, B. J., and Rosenbaum, J. S. (2001) Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121. J. Biol Chem. 276, 25520-25531
-
(2001)
J. Biol Chem.
, vol.276
, pp. 25520-25531
-
-
Whitaker, G.B.1
Limberg, B.J.2
Rosenbaum, J.S.3
-
26
-
-
0032925156
-
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
-
Carmeliet, P., Ng, Y. S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V., Perriard, J. C., Dewerchin, M., Flameng, W., Nagy, A., Lupu, F., Moons, L., Collen, D., D'Amore, P. A., and Shima, D. T. (1999) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5, 495-502
-
(1999)
Nat. Med.
, vol.5
, pp. 495-502
-
-
Carmeliet, P.1
Ng, Y.S.2
Nuyens, D.3
Theilmeier, G.4
Brusselmans, K.5
Cornelissen, I.6
Ehler, E.7
Kakkar, V.V.8
Stalmans, I.9
Mattot, V.10
Perriard, J.C.11
Dewerchin, M.12
Flameng, W.13
Nagy, A.14
Lupu, F.15
Moons, L.16
Collen, D.17
D'Amore, P.A.18
Shima, D.T.19
-
27
-
-
0036166701
-
Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
-
Maes, C., Carmeliet, P., Moermans, K., Stockmans, I., Smets, N., Collen, D., Bouillon, R., and Carmeliet, G. (2002) Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech. Dev. 111, 61-73
-
(2002)
Mech. Dev.
, vol.111
, pp. 61-73
-
-
Maes, C.1
Carmeliet, P.2
Moermans, K.3
Stockmans, I.4
Smets, N.5
Collen, D.6
Bouillon, R.7
Carmeliet, G.8
-
28
-
-
0036174063
-
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms
-
xE, sir, xE
-
Stalmans, I., Ng, Y.-S., Rohan, R., Fruttiger, M., Bouché, A., Yuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S., Hicklin, D., Anderson, D. J., Gardiner, T., Hammes, H.-P., Moons, L., Dewerchin, M., Collen, D., xE, sir, xE, Carmeliet, P., and D'Amore, P. A. (2002) Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109, 327-336
-
(2002)
J. Clin. Invest.
, vol.109
, pp. 327-336
-
-
Stalmans, I.1
Ng, Y.-S.2
Rohan, R.3
Fruttiger, M.4
Bouché, A.5
Yuce, A.6
Fujisawa, H.7
Hermans, B.8
Shani, M.9
Jansen, S.10
Hicklin, D.11
Anderson, D.J.12
Gardiner, T.13
Hammes, H.-P.14
Moons, L.15
Dewerchin, M.16
Collen, D.17
Carmeliet, P.18
D'Amore, P.A.19
-
29
-
-
0036339867
-
Skeletal defects in VEGF (120/120) mice reveal multiple roles for VEGF in skeletogenesis
-
Zelzer, E., McLean, W., Ng, Y. S., Fukai, N., Reginato, A. M., Lovejoy, S., D'Amore, P. A., and Olsen, B. R. (2002) Skeletal defects in VEGF (120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129, 1893-1904
-
(2002)
Development
, vol.129
, pp. 1893-1904
-
-
Zelzer, E.1
McLean, W.2
Ng, Y.S.3
Fukai, N.4
Reginato, A.M.5
Lovejoy, S.6
D'Amore, P.A.7
Olsen, B.R.8
-
30
-
-
33646076452
-
Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis
-
Jakobsson, L., Kreuger, J., Holmborn, K., Lundin, L., Eriksson, I., Kjellén, L., and Claesson-Welsh, L. (2006) Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev. Cell 10, 625-634
-
(2006)
Dev. Cell
, vol.10
, pp. 625-634
-
-
Jakobsson, L.1
Kreuger, J.2
Holmborn, K.3
Lundin, L.4
Eriksson, I.5
Kjellén, L.6
Claesson-Welsh, L.7
-
31
-
-
84897421093
-
NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation
-
Koch, S., Van Meeteren, L. A., Morin, E., Testini, C., Weström, S., Björkelund, H., Le Jan, S., Adler, J., Berger, P., and Claesson-Welsh, L. (2014) NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation. Dev. Cell 28, 633-646
-
(2014)
Dev. Cell
, vol.28
, pp. 633-646
-
-
Koch, S.1
Van Meeteren, L.A.2
Morin, E.3
Testini, C.4
Weström, S.5
Björkelund, H.6
Le Jan, S.7
Adler, J.8
Berger, P.9
Claesson-Welsh, L.10
-
32
-
-
0024818355
-
Vascular endothelial growth factor is a secreted angiogenic mitogen
-
Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309
-
(1989)
Science
, vol.246
, pp. 1306-1309
-
-
Leung, D.W.1
Cachianes, G.2
Kuang, W.J.3
Goeddel, D.V.4
Ferrara, N.5
-
33
-
-
0028990151
-
VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding tothe VEGF receptorsof human melanoma cells
-
Cohen, T., Gitay-Goren, H., Sharon, R., Shibuya, M., Halaban, R., Levi, B. Z., and Neufeld, G. (1995) VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding tothe VEGF receptorsof human melanoma cells. J. Biol. Chem. 270, 11322-11326
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 11322-11326
-
-
Cohen, T.1
Gitay-Goren, H.2
Sharon, R.3
Shibuya, M.4
Halaban, R.5
Levi, B.Z.6
Neufeld, G.7
-
34
-
-
0342547239
-
Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor
-
Dougher, A. M., Wasserstrom, H., Torley, L., Shridaran, L., Westdock, P., Hileman, R. E., Fromm, J. R., Anderberg, R., Lyman, S., Linhardt, R. J., Kaplan, J., and Terman, B. I. (1997) Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. Growth Factors 14, 257-268
-
(1997)
Growth Factors
, vol.14
, pp. 257-268
-
-
Dougher, A.M.1
Wasserstrom, H.2
Torley, L.3
Shridaran, L.4
Westdock, P.5
Hileman, R.E.6
Fromm, J.R.7
Anderberg, R.8
Lyman, S.9
Linhardt, R.J.10
Kaplan, J.11
Terman, B.I.12
-
35
-
-
0029083711
-
Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent
-
Chiang, M.-K., and Flanagan, J. G. (1995) Interactions between the Flk-1 receptor, vascular endothelial growth factor, and cell surface proteoglycan identified with a soluble receptor reagent. Growth Factors 12, 1-10
-
(1995)
Growth Factors
, vol.12
, pp. 1-10
-
-
Chiang, M.-K.1
Flanagan, J.G.2
-
36
-
-
0033517753
-
The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site
-
Park, M., and Lee, S.-T. (1999) The fourth immunoglobulin-like loop in the extracellular domain of FLT-1, a VEGF receptor, includes a major heparin-binding site. Biochem. Biophys. Res. Commun. 264, 730-734
-
(1999)
Biochem. Biophys. Res. Commun.
, vol.264
, pp. 730-734
-
-
Park, M.1
Lee, S.-T.2
-
37
-
-
0032776557
-
Structural features in heparin that interact with VEGF165 and modulate its biological activity
-
Ono, K., Hattori, H., Takeshita, S., Kurita, A., and Ishihara, M. (1999) Structural features in heparin that interact with VEGF165 and modulate its biological activity. Glycobiology 9, 705-711
-
(1999)
Glycobiology
, vol.9
, pp. 705-711
-
-
Ono, K.1
Hattori, H.2
Takeshita, S.3
Kurita, A.4
Ishihara, M.5
-
38
-
-
0038482067
-
Regulation of vascular endothelial growth factor binding and activity by extracellular pH
-
Goerges, A. L., and Nugent, M. A. (2003) Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J. Biol. Chem. 278, 19518-19525
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 19518-19525
-
-
Goerges, A.L.1
Nugent, M.A.2
-
39
-
-
84863075395
-
Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides
-
Zhao, W., McCallum, S. A., Xiao, Z., Zhang, F., and Linhardt, R. J. (2012) Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides. Biosci. Rep. 32, 71-81
-
(2012)
Biosci. Rep.
, vol.32
, pp. 71-81
-
-
Zhao, W.1
McCallum, S.A.2
Xiao, Z.3
Zhang, F.4
Linhardt, R.J.5
-
40
-
-
0034595635
-
Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells
-
Rahimi, N., Dayanir, V., and Lashkari, K. (2000) Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J. Biol. Chem. 275, 16986-16992
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 16986-16992
-
-
Rahimi, N.1
Dayanir, V.2
Lashkari, K.3
-
41
-
-
16344380942
-
The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation
-
Singh, A. J., Meyer, R. D., Band, H., and Rahimi, N. (2005) The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulation. Mol. Biol. Cell 16, 2106-2118
-
(2005)
Mol. Biol. Cell
, vol.16
, pp. 2106-2118
-
-
Singh, A.J.1
Meyer, R.D.2
Band, H.3
Rahimi, N.4
-
42
-
-
78650939979
-
Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability
-
Xu, D., Fuster, M. M., Lawrence, R., and Esko, J. D. (2011) Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability. J. Biol Chem. 286, 737-745
-
(2011)
J. Biol Chem.
, vol.286
, pp. 737-745
-
-
Xu, D.1
Fuster, M.M.2
Lawrence, R.3
Esko, J.D.4
-
43
-
-
84879807263
-
Determining the affinity and stoichiometry of interactions between unmodified proteins in solution using Biacore
-
Day, E. S., Capili, A. D., Borysenko, C. W., Zafari, M., and Whitty, A. (2013) Determining the affinity and stoichiometry of interactions between unmodified proteins in solution using Biacore. Anal. Biochem. 440, 96-107
-
(2013)
Anal. Biochem.
, vol.440
, pp. 96-107
-
-
Day, E.S.1
Capili, A.D.2
Borysenko, C.W.3
Zafari, M.4
Whitty, A.5
-
44
-
-
24744454378
-
Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells: Comparison of the effects of heparin and modified heparins
-
Ashikari-Hada, S., Habuchi, H., Kariya, Y., and Kimata, K. (2005) Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells: comparison of the effects of heparin and modified heparins. J. Biol. Chem. 280, 31508-31515
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 31508-31515
-
-
Ashikari-Hada, S.1
Habuchi, H.2
Kariya, Y.3
Kimata, K.4
-
45
-
-
0035955644
-
Vascular Endothelial Growth Factor 165 (VEGF165) Activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF165 and VEGF165-KDR complexes
-
Hamma-Kourbali, Y., Vassy, R., Starzec, A., Le Meuth-Metzinger, V., Oudar, O., Bagheri-Yarmand, R., Perret, G., and Crepin, M. (2001) Vascular Endothelial Growth Factor 165 (VEGF165) Activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF165 and VEGF165-KDR complexes. J. Biol. Chem. 276, 39748-39754
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 39748-39754
-
-
Hamma-Kourbali, Y.1
Vassy, R.2
Starzec, A.3
Le Meuth-Metzinger, V.4
Oudar, O.5
Bagheri-Yarmand, R.6
Perret, G.7
Crepin, M.8
-
46
-
-
34547520925
-
Structural basis for ligand and heparin binding to neuropilin B domains
-
Vander Kooi, C. W., Jusino, M. A., Perman, B., Neau, D. B., Bellamy, H. D., and Leahy, D. J. (2007) Structural basis for ligand and heparin binding to neuropilin B domains. Proc. Natl. Acad. Sci. U. S. A. 104, 6152-6157
-
(2007)
Proc. Natl. Acad. Sci. U. S. A.
, vol.104
, pp. 6152-6157
-
-
Vander Kooi, C.W.1
Jusino, M.A.2
Perman, B.3
Neau, D.B.4
Bellamy, H.D.5
Leahy, D.J.6
-
47
-
-
47949089077
-
VEGF-targeted therapy: Mechanisms of anti-tumour activity
-
Ellis, L. M., and Hicklin, D. J. (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer 8, 579-591
-
(2008)
Nat. Rev. Cancer
, vol.8
, pp. 579-591
-
-
Ellis, L.M.1
Hicklin, D.J.2
-
48
-
-
75349091269
-
Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling
-
Grünewald, F. S., Prota, A. E., Giese, A., and Ballmer-Hofer, K. (2010) Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling. Biochim. Biophys. Acta 1804, 567-580
-
(2010)
Biochim. Biophys. Acta
, vol.1804
, pp. 567-580
-
-
Grünewald, F.S.1
Prota, A.E.2
Giese, A.3
Ballmer-Hofer, K.4
-
49
-
-
0029021660
-
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
-
Fong, G.-H., Rossant, J., Gertsenstein, M., and Breitman, M. L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70
-
(1995)
Nature
, vol.376
, pp. 66-70
-
-
Fong, G.-H.1
Rossant, J.2
Gertsenstein, M.3
Breitman, M.L.4
-
50
-
-
66149086950
-
Positive and negative modulation of angiogenesis by VEGFR1 ligands
-
Cao, Y. (2009) Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci. Signal. 2, re1
-
(2009)
Sci. Signal.
, vol.2
, pp. re1
-
-
Cao, Y.1
-
51
-
-
0032482978
-
Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
-
Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., and Shibuya, M. (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 95, 9349-9354
-
(1998)
Proc. Natl. Acad. Sci. U. S. A.
, vol.95
, pp. 9349-9354
-
-
Hiratsuka, S.1
Minowa, O.2
Kuno, J.3
Noda, T.4
Shibuya, M.5
-
52
-
-
0037147259
-
Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans
-
Morimoto-Tomita, M., Uchimura, K., Werb, Z., Hemmerich, S., and Rosen, S. D. (2002) Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J. Biol. Chem. 277, 49175-49185
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 49175-49185
-
-
Morimoto-Tomita, M.1
Uchimura, K.2
Werb, Z.3
Hemmerich, S.4
Rosen, S.D.5
-
53
-
-
33644657201
-
HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: Effects on VEGF, FGF-1, and SDF-1
-
Uchimura, K., Morimoto-Tomita, M., Bistrup, A., Li, J., Lyon, M., Gallagher, J., Werb, Z., and Rosen, S. (2006) HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem. 7, 2
-
(2006)
BMC Biochem.
, vol.7
, pp. 2
-
-
Uchimura, K.1
Morimoto-Tomita, M.2
Bistrup, A.3
Li, J.4
Lyon, M.5
Gallagher, J.6
Werb, Z.7
Rosen, S.8
|